Becky Slack, M.S.
Senior Statistical Analyst
- M.S. in Biometry, Cornell University, Ithaca, NY
Kee BK, Morris JS, Slack RS, Crocenzi T, Wong L, Esparaz B, Overman M, Glover K, Jones D, Wen S, Fisch MJ. A phase II, randomized, double blind trial of calcium aluminosilicate clay versus placebo for the prevention of diarrhea in patients with metastatic colorectal cancer treated with irinotecan. Support Care Cancer 2014; Aug 27 [Epub ahead of print].
Deeken JF, Slack R, Weiss GJ, Ramanathan RK, Pishvaian MJ, Hwang J, Lewandowski K, Subramaniam D, He AR, Cotarla I, Rahman A, Marshall JL. 2013. A phase I study of limposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies. Cancer Chemother Pharmacol 71(3): 627-33.
Sexton ME, Baker JJ, Nakagawa K, Li Y, Perkins R, Slack RS, Baker DC, Jucha B, Arora S, Plankey MW. 2013. How reliable is self-testing for gonorrhea and chlamydia among men who have sex with men? J Fam Pract 62(2): 70-8.
Gurka MK, Collins SP, Slack R, Tse G, Charabaty A, Ley L, Berzcel L, Lei S, Suy S, Haddad N, Jha R, Johnson CD, Jackson P, Marshall JL, Pishvaian MJ. 2013. Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety. Radiat Oncol 8: 44.
Lee JH, Krishna SG, Singh A, Ladha H, Slack RS, Ramireddy S, Raju GS, Davila M, Ross WA. 2013. Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients. Gastrointest Endoscopy 2013; 878(2): 312-324.
Wisniewski W, Fournier KF, Ling YK, Slack RS, Babiera G, Grubbs EG, Hogue SK, Fleming JB, You YN. A focused curriculum in surgical oncology for third-year medical students. Journal of Surgical Research 2013; 185(2): 555-560.
Tripathi1 D, Chowdhury R, Trudel LJ, Tee AR, Slack RS, Walker CL, Wogan GN. Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2-mediated suppression of mTORC1. Proc Natl Acad Sci USA 2013; 110(32): E2950-7.
Raju GS, Vadyala V, Slack RS, Krishna SG, Ross WA, Lynch PM, Bresalier R, HawkE, Stroehlein JR. Adenoma detection in patients participating in a comprehensive colonoscopy screening program. Cancer Medicine 2013; 2(3): 391-402.
Korchak ME, Glazier RU, Slack RS, Plankey MW, Mayer HR. 201.2 Protective eyewear use as depicted in children’s television programs. J Pediatr Ophthalmol Strabismus 28: 1-6.
You YN, Roses RE, Chang GJ, Rodriguez-Bigas MA, Feig BW, Slack R, Nguyen S, Skibber JM. 2012. Multimodality salvage of recurrent disease after local excision for rectal cancer. Dis Colon Rectum 55(12): 1213-9.
Pishviain M, Slack R, Koh E, Beumer J, Hartley M, Cotarla I, Deeken J, He A, Hwang J, Malik S, Strychor S, Egorin M, Marshall J. 2012. A phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy. Cancer Chemother Pharmacol 70:843-53.
Li Y, Baker JJ, Korostyshevskiy VR, Slack RS, Plankey MW. 2012. The association of intimate partner violence, recreational drug use with HIV seroprevalence among MSM. AIDS Behavior 16(3): 491-8.
Isaacs C, Herbolsheimer P, Liu MC, Wilkinson M, Ottaviano Y, Chung GG, Warren R, Eng-Wong J, Cohen P, Smith KL, Creswell K, Novielli A, Slack R. 2011. Phase I/II study of sorafenib with anastrozole to overcome resistance to aromatase inhibitors in patients with hormone receptor positive (ER/PR+) aromatase inhibitor resistant metastatic breast cancer. Breast Cancer Research and Treatment 125(1): 137-143.
Unger KR, Lominska CE, Deeken JF, Davidson BJ, Newkirk KA, Gagnon GJ, Hwang J, Slack RS, Noone A-M, Harter KW. 2010. Fractionated stereotactic radiosurgery for reirradiation of head and neck cancer. International Journal of Radiation Oncology, Biology, and Physics 77(6): 1411-1419.
Oermann E, Slack R, Hanscom H, Lei S, Suy S, Park H, Kim J, Sherer B, Collins B, Satinsky A, Harter KW, Patipps G, Constantinope N, Dejter S, Maxted W, Regan J, Pahira J, McGeach K, Jha R, Dawson N, Dritschilo A, Lynch J, Collins S. 2010. A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer. Technology in Cancer Research and Treatment 9(5): 453-461.
Loprinzi CL, Sloan J, Stearns V, Slack R, Iyengar M, Diekmann B, Kimmick G, Lovato J, Gordon P, Pandya K, Guttuso T Jr, Barton D, Novotny P. 2009. Newer antidepressants and gabapentin for hot flashes: An individual patient pooled analysis. Journal of Clinical Oncology 27(17): 2831-7.
Shah R, Selby ST, Yokley B, Slack RS, Hurley CK, Posch P. 2009. TNF, LTA and TGFB1 genotype distributions among acute graft-versus-host disease (AGVHD) subsets after HLA-matched unrelated hematopoietic stem cell transplantation: A pilot study. Tissue Antigens 74(1): 50-6.
Baker J, Plankey M, Josayma Y,Elion R, Chiliade P, Shahkolahi A, Menna M, Miniter K, Slack R, Yang Y, Masterman B, Margolick JB. 2009. The prevalence of rectal, urethral, and pharyngeal Neisseria gonorrheae and Chlamydia trachomatis among asymptomatic men who have sex with men in a prospective cohort in Washington, D.C. AIDS Patient Care and STDs 23(8): 1-4.
Sun JF, Wu RR, Norris C, Noone A-M, Amankwa-Sakyi M, Slack R, Marshall JL. 2009. Safety of chronic low-dose capecitabine as maintenance therapy in gastrointestinal cancers. Gastrointestinal Cancer Research 3(4): 134-40.
Wu RR, Lindenberg PA, Slack R, Noone A-M, Marshall JL, He AR. 2009. Evaluation of hypertension as a marker of bevacizumab efficacy. Journal of Gastrointestinal Cancer 40(3-4): 101-8
Deeken J, Slack R, Marshall J. 2008. Irinotecan and uridine diphosphate glucuronosyltransferase 1A1 pharmacogenetics: To test or not to est, that is the question. Cancer 133(7): 1502-10.
White AM, Banovac F, Yousefi S, Slack RS, Spies JB. 2007. Uterine fibroid embolization: The utility of aortography in detecting ovarian artery collateral supply. Radiology 244(1): 291-8.
Bowden ET, Onikoyi E, Slack R, Myoui A, Yoneda T, Yamada KM. 2006. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Experimental Cell Research 312(8): 1240-53.
Lazaro AM, Steiner NK, Cao K, Slack R, Chen DS, Xiao Y, Beduhn E, Ng J, Hartzman RJ, Hurley CK. 2006. Searching for HLA-DRB1*1206 in volunteer marrow donors in four US population groups. Tissue Antigens 68: 439-41.
Marshall JL, Gulley JL, Arlen P, Beetham PK, Tsang K-Y, Slack R, Hodge JW, Doren S, Grosenbach DW, Hwang J, Fox E, Odogwu L, Park S, Panicali D, Schlom J. 2005. Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinica-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas. Journal of Clinical Oncology 23(4): 1-12.
Chepko G, Slack R, Carbott D, Kahn S, Stedman L, Dickson RB. 2005. Cell type population sizes and cell cycle activity are differentially altered in ducts and lobules of TGFα and c-Myc transgenic mouse mammary epithelium. Tissue and Cell 37: 393-412.
Isaacs C, Slack RS, Gehan EA, Ballen K, Boccia R, Areman E, Hayes DF, Herscowitz H, Lippman M. 2005. A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patients. Breast Cancer Research and Treatment 93: 125-34.
Stearns V, Slack R, Greep N, Henry-Tilman R, Osborne M, Bunnel C, Ullmer L, Gallagher A, Cullen J, Gehan EA, Hayes DF, Isaacs C. 2005. Paroxetine is an effective treatment for hot flashes: Results from a prospective randomized clinical trial. Journal of Clinical Oncology 23(28): 6919-30.
Pack SD, Alper OM, Stromberg K, Augustus M, Ozdemirli M, Miermont AM, Klus G, Rusin M, Slack R, Gacker NF, Ried T, Szallasi Z, Alper O. 2004. Simultaneous suppression of EGFR and c-erbB-2 reverses aneuploidy and malignant phenotype of a human ovarian carcinoma cell line. Cancer Research 64(3): 789-94.
Stearns V, Singh B, Tsangaris T, Crawford J, Novielli A, Ellis MJ, Isaacs C, Pennanen M, Tibery C, Farhad A, Slack R, Hayes DF. 2003. A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer. Clinical Cancer Research 9: 124-33.
Baldassarre LA, Steiner NK, Jones P, Tang T, Slack R, Ng J, Hartzman RJ, Hurley CK. 2003. Limited diversity of HLA-DRB1*02 Alleles and DRB1-DRB5 haplotype associations in four United States populations groups. Tissue Antigens 61: 249-52.
Rizzuto G, Li L, Steiner N, Slack R, Tang T, Heine U, Lin Y, Ng J, Hartzman RJ, Hurley CK. 2003. Diversity within the DRB1*08 allele family in four populations from a United States hematopoietic stem cell donor database and characterization of five novel DRB1*08 alleles. Human Immunology 64: 607-13.
Han Z, Slack RS, Li W, Papadopoulos V. 2003. Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression. Journal of Receptors and Signal Transduction Research 23(2-3): 225-38.
Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN. 2002. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Annals of Surgical Oncology 9(3): 235-42.
Abu-Ghosh AM, Krailo MD, Goldman SC, Slack RS, Davenport VG, Morris EK, Laver JH, Reaman GH, Cairo MS. 2002. Ifosfamide, carboplatin, and etoposide in children with poor-risk relapsed Wilm’s tumor: A Children’s Cancer Group (CCG) report. Annals of Oncology 13: 460-9.
Meehan K, Slack R, Gehan E, Herscowitz H, Areman E, Ebadi M, Cairo M, Lippman M. 2002. Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patients. Journal of Hematotherapy and Stem Cell Research 11(2): 415-21.
Gans CP, Tang TF, Slack R, Ng J, Hartzman RJ, Hurley CK. 2002. DRB1*14 diversity and DRB3 associations in four major population groups in the United States. Tissue Antigens 59(5): 364-9.
Chen DS, Tang TF, Pulyaeva H, Slack R, Tu B, Wagage D, Noreen H, Perlee L, Ng J, Hartzman RJ, Hurley CK. 2002. Relative HLA-DRB1*04 allele frequencies in the five major populations in the United States and six new DRB1*04 alleles. Human Immunology 63(8): 665-72.
Houtenbous I, Bracho F, Davenport V, Slack R, Van de Ven C, Suen Y, Killen R, Shen V, Sender L, Cairo M. 2001. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of auto graft vs leukemia effect and post transplant immuno and chemotherapy. Bone Marrow Transplantation 27(2): 145-53.
Meehan KR, Wu A, Hassan R, Miao Y, Chawla J, Slack R, Gehan E, Herscowitz HB. 2001. Ex vivo cytokine activation of peripheral blood stem cells: A potential role for adoptive cellular immunotherapy. Journal of Hematotherapy & Stem Cell Research 10: 283-90.
Goldman SC, Bracho F, Davenport V, Slack R, Areman E, Shen V, Lenarsky C, Weinthal J, Hughes R, Cairo MS. 2001. A feasibility study of interleukin-11 and G-CSF following myelosuppressive chemotherapy to mobilize peripheral blood stem cells (DC34+) from heavily pretreated patients. American Journal of Pediatric Hematologic Oncology 23(5): 300-5.
Yang X, Wei L, Tang C, Slack R, Mueller M, Lippman M. 2001. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Research 16(13): 5284-8.
Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J, Kallioniemi O, Gelmann EP. 2000. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Research 60(21): 6111-5.
Collins M, Tang T, Slack R, Sintasath D, Hartzmann RJ, Ng J, Hurley CK. 2000. The relative frequencies of HLA-DRB1*01 alleles in the major U.S. populations. Tissue Antigens 55: 48-52.
Ellis J, Henson V, Slack R, Ng J, Hartzman RJ, Hurley CK. 2000. The frequencies of HLA-A2 alleles in five U.S. population groups: Predominance of A*02011 and identification of HLA-A*0231. Human Immunology 61: 334-40.
Kosman C, Steiner N, Pulyaeva H, Mitton W, Slack R, Hartzman RJ, Ng J, Hurley CK. 2000. The relationship between HLA-B45 and B*5002 in the five major U.S. population groups. Tissue Antigens 55: 437-42.
Pimtanothai N, Rizzuto GA, Slack R, Steiner NK, Kosman CA, Jones PF, Koester R, Ng J, Hartzman R, Hurley CK. 2000. The diversity of alleles encoding HLA-B40: The relative frequencies in U.S. populations and description of five novel alleles. Human Immunology 61(8): 808-15.
Yang X, Wei L, Tang C, Slack R, Montgomery E, Lippman M. 2000. KAI1 protein is down-regulated during the progression of human breast cancer. Clinical Cancer Research 6(9): 3424-9.
Tang T, Huang A, Pappas A, Slack R, Ng J, Hartzman RJ, Hurley C. 2000. Relative frequencies of DRB1*11 alleles and their DRB3 associations in five major population groups in the United States. Human Immunology 61(8): 820-7.
Arun B, Slack R, Gehan E, Spitzer T, Meehan K. 1999. Survival after autologous hematopoetic stem cell transplantation for patients with inflammatory breast cancer. Cancer 85(1): 93-9.
Hsu E, Bei M, Slack R, Hartzman R, Ng J, Hurley C. 1999. HLA-A*28 allele frequencies in the five major U.S. ethnic groups. Human Immunology 60: 159-67.
Wu A, Michejda M, Mazumder A, Meehan K, Menendez F, Tchabo J-G, Slack R, Johnson M, Bellanti J. 1999. Analysis and characterization of hematopoietic progenitor cells from fetal bone marrow, adult bone marrow, peripheral blood and cord blood. Pediatric Research, 46(2): 163-9.
Bei M, Ng J, Slack R, Ellis J, Hartzman RJ, Hurley CK. 1999. The relative frequencies of HLA-A*10 alleles in five major U.S. ethnic populations. Tissue Antigens 54: 295-9.
Sintasath, DM, Tang T, Slack R, Tilley EE, Ng J, Hartzman RJ, Hurley CK. 1999. Relative HLA DRB1*13 allele frequencies and DRB3 associations of unrelated individuals from five U.S. populations. Human Immunology 60: 1001-10.
Burnett C, Steakley C, Slack R, Roth J, Lerman C. 1999. Patterns of breast cancer screening among lesbians at increased risk for breast cancer. Women and Health 29: 35-55.
Hanfelt J, Slack R, Gehan E. 1999. A modified version of Simon’s optimal design where the criterion is the median sample size. Controlled Clinical Trials 20: 555-66.
Updated April 22, 2013